In Utero Exposure to Forever Chemicals Higher Than Previously Thought
via HealthDayTUESDAY, Feb. 24, 2026 -- Infants are exposed to a wider range of per- and polyfluoroalkyl substances (PFAS) before birth than previously thought, according to a study published online Feb. 18 in Environmental Science & Technology.
Shelley H. Liu, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined PFAS exposure in archived umbilical cord blood samples collected between 2003 and 2006 from participants in the Health Outcomes and Measures of the Environment (HOME) Study. Participants included those who had targeted PFAS analysis data collected (216 mother-infant dyads) and those who had nontargeted PFAS data collected (120 mother-infant dyads).
The researchers found that a nontargeted chemical analysis method detected many more PFAS chemicals in umbilical cord blood than traditional testing methods, including newer and understudied compounds. The nontargeted approach identified 42 confirmed or putatively identified PFAS chemicals in cord blood, many of which are not commonly screened for in traditional testing methods and for which health effects are unknown, including perfluorinated chemicals, polyfluorinated chemicals, and fluorotelomers. A targeted analysis identified four PFAS.
"Our study helps show that prenatal PFAS exposure is more complex and widespread than earlier studies suggested," Liu said in a statement. "Understanding the full picture is essential if we want to protect child health and reduce preventable environmental risks."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-25 01:56
Read more
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- Risk Factors Associated With Child Food Allergy Identified
- Anxiety in Teens: What to Know
- FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
- SMFM: Prenatal COVID-19 Vaccine Does Not Impact Neurodevelopmental Outcomes in Offspring
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions